Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
Charles River Laboratories (NYSE: CRL) has launched its first Charles River Accelerator and Development Lab (CRADL) in Chicago, enhancing contract vivarium space for the biopharmaceutical sector in Illinois. Located in Fulton Market, this facility supports both emerging and established companies by providing on-demand laboratory space, fostering rapid project initiation. The CRADL-Explora Vivarium Network now encompasses 28 facilities across key locations, providing over 380,000 square feet of rental capacity, supporting the growth of the biotech ecosystem.
- Opening of first CRADL in Chicago enhances contract vivarium space.
- Supports rapid project initiation for biopharmaceutical companies.
- Expands CRADL-Explora Vivarium Network to 28 facilities and 380,000 square feet.
- Strengthens the biotech ecosystem in Chicago's Fulton Market.
- None.
CRADL Chicago is located in
The Combined Expertise and
With the acquisition of Explora BioLabs in
Approved Quotes
-
“Chicago is emerging as a key biohub in
the United States , with a growing life sciences community. By providing contract vivarium services, we’re able to support clients in starting projects quickly, without the burden of building infrastructure, which can be costly and time consuming.” –Colin Dunn, Ph.D., Corporate Senior Vice President, Global Research Models & Services, Charles River -
"Charles River has the largest network of contract vivarium facilities globally, and we're thrilled to have one at our
Fulton Market location. Their depth of experience provides an incredible opportunity for the life sciences community inChicago and other biotech communities. We're glad to have established a relationship with a world-class organization like Charles River, and we look forward to working together in the future.” —John Flavin, Founder and CEO, Portal Innovations
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005019/en/
Investor:
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Media:
Corporate Vice President, Chief Communications Officer
781.222.6168
amy.cianciaruso@crl.com
Source:
FAQ
What did Charles River Laboratories announce regarding CRADL in Chicago?
How does the CRADL in Chicago benefit biopharmaceutical companies?
What is the significance of the CRADL-Explora Vivarium Network?
How large is the CRADL-Explora Vivarium Network?